i
Home
About
Aggregate Report
FAQs
Contact Us
Login
Report Details
2017 - 2022 (Research in equity and health)
Results 1 - 2 of 2
Public Name
Status
Date Registered
Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (ACCESS 2) . . .
Registry ID:
PHRR220418-004539
Ongoing
18 Apr 2022
A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmo . . .
Registry ID:
PHRR220520-004684
Pending
20 May 2022